10 completed, 1 unknown. 11 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 10, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Trematode Infections: new trials by email Literature Review of Trematode Infections trials Research Report on Trematode Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the rSm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar rSm-p80 + GLA-SE - Schistosomiasis | Phase 1 | Completed | International Vaccine Institute | 120 | 2023-11-17 | 2026-04-29 |
| Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults Sm-p80, Sm-p80 + GLA-SE - Schistosomiasis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2022-05-23 | 2025-07-14 |
| Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701, ENGERIX-B Hepatitis B Vaccine - Schistosomiasis, Schistosoma Mansoni | Phase 1 / Phase 2 | Completed | Baylor College of Medicine | 290 | 2019-10-07 | 2025-11-04 |
| A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults GLA-AF, Hepatitis B Virus Vaccine (Recombinant), Sm-TSP-2/Alhydrogel - Schistosomiasis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2018-05-20 | 2021-02-02 |
| Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers Oxfendazole - Helminthic Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2017-05-12 | 2019-12-17 |
| A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults Placebo, Sm-TSP-2/Alhydrogel, Sm-TSP-2/Alhydrogel/GLA-AF - Schistosomiasis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2015-02-04 | 2017-06-26 |
| Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet - Ulcerative Colitis, Ulcerative Colitis Exacerbation | Phase 1 / Phase 2 | Unknown | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 300 | 2015-01-01 | 2023-03-03 |
| Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS DNA, AIDSVAX B/E - HIV/AIDS | Phase 1 | Completed | EuroVacc Foundation | 72 | 2014-09-01 | 2016-01-22 |
| Praziquantel-Pharmacokinetic Study Praziquantel - Schistosomiasis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 47 | 2012-01-01 | 2019-01-18 |
| Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis sm14 antigen plus adjuvant GLA - Schistosomiasis | Phase 1 | Completed | Oswaldo Cruz Foundation | 20 | 2011-03-01 | 2016-08-10 |
| Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis rSh28GST - Schistosomiasis, Bilharziasis | Phase 1 | Completed | University Hospital, Lille | 24 | 1998-09-01 | 2013-08-27 |
Schistosomiasis (8) · Acquired Immunodeficiency Syndrome (1) · Colitis, Ulcerative (1) · Protozoan Infections (1) · Schistosomiasis haematobia (1)
Helminthiasis (11) · Infections (11) · Parasitic Diseases (11) · Vector Borne Diseases (8) · Urogenital Diseases (2) · Blood-Borne Infections (1) · Colitis (1) · Colonic Diseases (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1)
AIDSVAX B-E (1) · DNA (1) · GLA-AF adjuvant (1) · Hepatitis B Vaccines (1) · Mesalamine (1) · Praziquantel (1) · Tablets (1) · nitazoxanide (1) · oxfendazole (1)
National Institute of Allergy and Infectious Diseases (NIAID) (5) · Baylor College of Medicine (1) · EuroVacc Foundation (1) · International Vaccine Institute (1) · Oswaldo Cruz Foundation (1) · Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (1) · University Hospital, Lille (1)
United States (3) · Brazil (2) · Uganda (2) · Burkina Faso (1) · France (1) · Madagascar (1) · Philippines (1)
Florian Marks (1) · Hannah Kibuuka, MD (1) · Marilia S Oliveira, MD, MsC (1) · Pontiano Kaleebu (1)
PMID 22802974, PMID 26571311, PMID 32816721, PMID 33188747, PMID 36996185, PMID 41285840
5UM1AI148373-03 (1), U01AI066050 (1)